Q4 2023 Holdings
Filed 2024-02-13 | 43 holdings | $439.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $85.3M | 1,451,925 | 19.4% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $50.2M | 5,001,580 | 11.4% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $37.5M | 165,123 | 8.5% |
| The Cigna Group(CI) | COM | 125523100 | $34.9M | 116,553 | 7.9% |
| Globus MED Inc(GMED) | CL A | 379577208 | $28.4M | 532,089 | 6.5% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $26.7M | 861,700 | 6.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $21.2M | 571,391 | 4.8% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $19.1M | 644,366 | 4.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $17.6M | 80,050 | 4.0% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $13.9M | 736,008 | 3.2% |
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $13.6M | 141,300 | 3.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $10.5M | 460,044 | 2.4% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $9.1M | 36,527 | 2.1% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $8.8M | 72,300 | 2.0% |
| Neogen Corp(NEOG)Put | COM | 640491106 | $8.6M | 427,000 | 2.0% |
| Healthcare Svcs Group Inc(HCSG) | COM | 421906108 | $8.4M | 810,307 | 1.9% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $6.1M | 1,105,911 | 1.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.3M | 131,753 | 1.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $4.3M | 971,446 | 1.0% |
| Merrimack Pharmaceuticals in(MACKEUR) | COM NEW | 590328209 | $3.9M | 288,466 | 0.9% |
| Harpoon Therapeutics Inc | COM NEW | 41358P205 | $3.4M | 297,936 | 0.8% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $3.0M | 3,588,427 | 0.7% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $2.4M | 246,036 | 0.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $2.2M | 251,532 | 0.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $2.1M | 635,969 | 0.5% |
| Ironwood Pharmaceuticals Inc(IRWD)Put | COM CL A | 46333X108 | $1.9M | 163,400 | 0.4% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $1.8M | 163,363 | 0.4% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $1.4M | 320,394 | 0.3% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $1.3M | 280,000 | 0.3% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $1.3M | 689,352 | 0.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.2M | 33,007 | 0.3% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $928.4K | 200,076 | 0.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $906.0K | 150,000 | 0.2% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $784.8K | 121,672 | 0.2% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $411.9K | 97,616 | 0.1% |
| Inogen Inc(INGN) | COM | 45780L104 | $289.8K | 52,794 | 0.1% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $172.0K | 400,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $148.2K | 130,000 | 0.0% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $132.7K | 254,150 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $120.4K | 102,049 | 0.0% |
| Humacyte Inc | *W EXP 08/27/202 | 44486Q111 | $21.6K | 49,998 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $15.3K | 30,741 | 0.0% |
| Caremax Inc | *W EXP 06/08/202 | 14171W111 | $175 | 12,808 | 0.0% |